Technical Hurdles, Commercial Limits Complicate Supplement-To-Drug Moves
This article was originally published in The Tan Sheet
Executive Summary
Firms should investigate regulatory hurdles and gauge the commercial appeal of a finished product before moving dietary supplement ingredients into the pharmaceutical realm, say manufacturing and testing consultants